litlas
ログインアカウント作成

Terry L. Smith

1974–2012 年に発表

79
論文数
22,356
被引用数
76
h 指数
78
i10 指数

被引用数

Terry L. Smith の年別被引用数1976 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 5 件1980 年: 被引用 20 件1981 年: 被引用 26 件1982 年: 被引用 25 件1983 年: 被引用 25 件1984 年: 被引用 19 件1985 年: 被引用 22 件1986 年: 被引用 25 件1987 年: 被引用 35 件1988 年: 被引用 19 件1989 年: 被引用 34 件1990 年: 被引用 32 件1991 年: 被引用 30 件1992 年: 被引用 28 件1993 年: 被引用 40 件1994 年: 被引用 38 件1995 年: 被引用 55 件1996 年: 被引用 45 件1997 年: 被引用 48 件1998 年: 被引用 58 件1999 年: 被引用 91 件2000 年: 被引用 112 件2001 年: 被引用 120 件2002 年: 被引用 160 件2003 年: 被引用 233 件2004 年: 被引用 184 件2005 年: 被引用 196 件2006 年: 被引用 235 件2007 年: 被引用 228 件2008 年: 被引用 175 件2009 年: 被引用 183 件2010 年: 被引用 200 件2011 年: 被引用 153 件2012 年: 被引用 183 件2013 年: 被引用 135 件2014 年: 被引用 124 件2015 年: 被引用 137 件2016 年: 被引用 120 件2017 年: 被引用 109 件2018 年: 被引用 96 件2019 年: 被引用 325 件2020 年: 被引用 340 件2021 年: 被引用 256 件2022 年: 被引用 158 件2023 年: 被引用 98 件2024 年: 被引用 179 件2025 年: 被引用 60 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,450 件、この内訳の 31.8%イギリス: 引用元論文 527 件、この内訳の 6.8%ドイツ: 引用元論文 492 件、この内訳の 6.4%イタリア: 引用元論文 466 件、この内訳の 6%フランス: 引用元論文 442 件、この内訳の 5.7%オランダ: 引用元論文 305 件、この内訳の 4%カナダ: 引用元論文 270 件、この内訳の 3.5%中国: 引用元論文 262 件、この内訳の 3.4%スペイン: 引用元論文 206 件、この内訳の 2.7%オーストラリア: 引用元論文 197 件、この内訳の 2.6%スイス: 引用元論文 189 件、この内訳の 2.4%日本: 引用元論文 162 件、この内訳の 2.1%
0%31.8%その他 22.6%

機関

分野

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology18.9%
  • Psychology3.2%
  • Computer Science2.9%
  • Social Sciences1.9%
  • Neuroscience1.6%
  • その他4.9%

トピック

  • Breast Cancer Treatment Studies5.4%
  • Acute Myeloid Leukemia Research4.1%
  • HER2/EGFR in Cancer Research3.2%
  • Acute Lymphoblastic Leukemia research2.8%
  • Chronic Myeloid Leukemia Treatments2.7%
  • Breast Lesions and Carcinomas2.4%
  • その他79.4%

共著者

全論文

検索で開く
  1. A note on quantifying follow-up in studies of failure time

    著者: M. Schemper, Terry L. Smith - Controlled Clinical Trials 1996 被引用: 2,547

  2. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    著者: Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith, Jörge E. Cortes, Francis J. Giles, Miloslav Beran, Sherry Pierce, Yang O. Huh, Michael Andreeff, Charles Koller, Chul S. Ha, Michael J. Keating, Sharon Murphy, Emil J. Freireich - Journal of Clinical Oncology 2000 被引用: 795

  3. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    著者: Henry M. Kuerer, Lisa A. Newman, Terry L. Smith, Fred C. Ames, Kelly K. Hunt, Kapil Dhingra, Richard L. Theriault, Gurpreet Singh, Susan M. Binkley, Nour Sneige, Thomas A. Buchholz, Merrick I. Ross, Marsha D. McNeese, Aman U. Buzdar, Gabriel N. Hortobágyi, S. Eva Singletary - Journal of Clinical Oncology 1999 被引用: 1,337

  4. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    著者: Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis, Daniel J. Booser, Eva Thomas, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, Banu Arun, Sharon H. Giordano, Massimo Cristofanilli, Debra Frye, Terry L. Smith, Kelly K. Hunt, S. Eva Singletary, Ayşegül A. Şahin, Michael S. Ewer, Thomas A. Buchholz, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2005 被引用: 1,170

  5. Independent validation of apache ii severity of illness score for predicting mortality in patients with breast cancer admitted to the intensive care unit

    著者: Judith A. Headley, Richard L. Theriault, Terry L. Smith - Cancer 1992 被引用: 90

  6. Primary refractory and relapsed adult acute lymphoblastic leukemia

    著者: Deborah A. Thomas, Hagop M. Kantarjian, Terry L. Smith, Charles Koller, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, James Gajewski, Sherry Pierce, Michael J. Keating - Cancer 1999 被引用: 197

  7. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

    著者: Radhika Rajan, Anna W. Poniecka, Terry L. Smith, Ying Yang, Deborah Frye, Lajos Pusztai, Derek J. Fiterman, Eva C. Gal-Gombos, Gary J. Whitman, Roman Rouzier, Marjorie Green, Henry M. Kuerer, Aman U. Buzdar, Gabriel N. Hortobágyi, W. Fraser Symmans - Cancer 2004 被引用: 163

  8. Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia

    著者: Hagop M. Kantarjian, Moshe Talpaz, Terry L. Smith, Jörge E. Cortes, Francis J. Giles, Mary Beth Rios, Susie Mallard, James Gajewski, Anthony J. Murgo, Bruce D. Cheson, Susan O’Brien - Journal of Clinical Oncology 2000 被引用: 94

  9. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

    著者: Philip Greenberg, Gabriel N. Hortobágyi, Terry L. Smith, L. D. Ziegler, D. Frye, Aman U. Buzdar - Journal of Clinical Oncology 1996 被引用: 754

  10. Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer

    著者: Francisco J. Esteva, Vicente Valero, Daniel J. Booser, Laura T. Guerra, James L. Murray, Lajos Pusztai, Massimo Cristofanilli, Banu Arun, Bita Esmaeli, Herbert A. Fritsche, Nour Sneige, Terry L. Smith, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2002 被引用: 572

  11. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

    著者: Francesco Onida, Hagop M. Kantarjian, Terry L. Smith, Greg Ball, Michael J. Keating, Elihu H. Estey, Armand B. Glassman, Maher Albitar, Monica Kwari, Miloslav Beran - Blood 2002 被引用: 386

  12. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?

    著者: Robert M. Byers, Adel K. El-Naggar, Ya-Yen Lee, Basharah Rao, Bruno D. Fornage, Nicholas H. A. Terry, Dory Sample, Patti Hankins, Terry L. Smith, Patricia J. Wolf - Head & Neck 1998 被引用: 313

  13. Early and delayed clinical cardiotoxicity of doxorubicin

    著者: Aman U. Buzdar, Connie Marcus, George R. Blumenschein, Terry L. Smith - Cancer 1985 被引用: 301

  14. Prognostic significance of phosphorylated P38 mitogen‐activated protein kinase and HER‐2 expression in lymph node‐positive breast carcinoma

    著者: Francisco J. Esteva, Ayşegül A. Şahin, Terry L. Smith, Ying Yang, Lajos Pusztai, Rita Nahta, Thomas A. Buchholz, Aman U. Buzdar, Gabriel N. Hortobágyi, Sarah Bacus - Cancer 2004 被引用: 128

  15. Is breast cancer survival improving?

    著者: Sharon H. Giordano, Aman U. Buzdar, Terry L. Smith, Shu‐Wan Kau, Ying Yang, Gabriel N. Hortobágyi - Cancer 2003 被引用: 544

  16. High Serum Lactate Dehydrogenase Level as a Marker for Drug Resistance and Short Survival in Multiple Myeloma

    著者: Meletios Α. Dimopoulos, Bart Barlogie, Terry L. Smith, R Alexanian - Annals of Internal Medicine 1991 被引用: 208

  17. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

    著者: Hagop M. Kantarjian, R S Walters, Michael J. Keating, Terry L. Smith, Stephen O’Brien, Elihu H. Estey, Yang O. Huh, Jorge A. Spinolo, K. A. Dicke, Barthel Barlogie - Journal of Clinical Oncology 1990 被引用: 170

  18. Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

    著者: Ralph Zinner, Bonnie S. Glisson, Frank V. Fossella, Katherine M.W. Pisters, Merril Kies, Pamela M. Lee, Erminia Massarelli, Bradley S. Sabloff, Herbert A. Fritsche, Jae Y. Ro, Nelson G. Ordóǹez, Hai T. Tran, Ying Yang, Terry L. Smith, R. Mass, Roy S. Herbst - Lung Cancer 2003 被引用: 125

  19. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia

    著者: Francesco Onida, Greg Ball, Hagop M. Kantarjian, Terry L. Smith, Armand B. Glassman, Maher Albitar, Barbara Scappini, Mary Beth Rios, Michael J. Keating, Miloslav Beran - Cancer 2002 被引用: 101

  20. Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers

    著者: Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne, Kristine S. Klos, Keng‐Hsueh Lan, Ying Yang, Wentao Yang, Terry L. Smith, Daren Shi, Dihua Yu - Clinical Cancer Research 2004 被引用: 312

  21. Chronic myelogenous leukemia in blast crisis

    著者: Hagop M. Kantarjian, Michael J. Keating, Moshe Talpaz, Ronald S. Walters, Terry L. Smith, Ann Cork, K. B. McCredie, Emil J. Freireich - The American Journal of Medicine 1987 被引用: 281

  22. Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

    著者: Donna Przepiorka, Terry L. Smith, Jody Folloder, Issa F. Khouri, Naoto T. Ueno, Rakesh Mehra, Martin Körbling, Yang O. Huh, Sergio Giralt, James Gajewski, Michèle L. Donato, Karen R. Cleary, David F. Claxton, Ira Braunschweig, Koen van Besien, Börje S. Andersson, Paolo Anderlini, Richard E. Champlin - Blood 1999 被引用: 223

  23. Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer

    著者: Jorge Bastarrachea, Gabriel N. Hortobagyi, Terry L. Smith, Shu-Wan C. Kau, Aman U. Buzdar - Annals of Internal Medicine 1994 被引用: 174

  24. Female patients with breast carcinoma age 30 years and younger have a poor prognosis

    著者: Qinghua Xiong, Vicente Valero, Vincent Kau, Shu‐Wan Kau, Sarah Taylor, Terry L. Smith, Aman U. Buzdar, Gabriel N. Hortobágyi, Richard L. Theriault - Cancer 2001 被引用: 168